Related Experiment Video
Updated: Aug 8, 2026

Neural Tube Closure in Mouse Whole Embryo Culture
Published on: October 21, 2011
Prevention of neural tube defects: vitamins, enzymes and genes
1Neural Development Unit, University College London, UK. a.copp@ich.ucl.ac.uk
Abstract:
Neural tube defects can be prevented by folic acid, although the mechanism of this action is unclear. Studies of a series of folate-related enzymes have so far failed to pin-point the nature of the metabolic defect in the neurulation-stage embryo that is corrected by folic acid. Approximately 30% of neural tube defects appear resistant to folic acid and recent work in a mouse genetic model system suggests that administration of myo-inositol may be a complementary therapeutic option. The large number of mouse genes known to cause neural tube defects provide a starting point for identifying the genetic basis of the human defects.
Insights
Folic acid may prevent neural tube defects, but its mechanism remains unclear for many cases. Myo-inositol shows promise as a complementary therapy for folate-resistant defects.
Area of Science:
- Developmental biology
- Genetics
- Nutritional science
Background:
- Neural tube defects (NTDs) are congenital abnormalities with significant public health impact.
- Folic acid is known to prevent NTDs, but the underlying metabolic mechanisms are not fully understood.
- A subset of NTDs (~30%) is resistant to folic acid intervention.
Purpose of the Study:
- To investigate the unclear mechanism of folic acid in preventing neural tube defects.
- To explore myo-inositol as a potential complementary therapeutic strategy for folate-resistant NTDs.
- To leverage genetic models for identifying the basis of human NTDs.
Main Methods:
- Analysis of folate-related enzymes in embryos during neurulation.
- Evaluation of myo-inositol administration in mouse genetic models of NTDs.
- Utilizing known mouse genes associated with NTDs to identify genetic causes.
Main Results:
- Current studies on folate-related enzymes have not identified the precise metabolic defect corrected by folic acid.
- Mouse genetic models suggest myo-inositol may offer a complementary approach for specific NTDs.
- A substantial number of mouse genes linked to NTDs exist, offering a resource for human genetic studies.
Conclusions:
- The exact mechanism by which folic acid prevents neural tube defects requires further elucidation.
- Myo-inositol presents a potential therapeutic avenue for folate-resistant neural tube defects.
- Mouse genetic models are valuable tools for uncovering the genetic etiology of human NTDs.
Related Concept Videos
In-vitro Mutagenesis
Neurulation
Cancer Prevention
Some...
Cancer Prevention
Some...
Teratogenicity
Biosynthesis of Nucleic Acids

